The increase in the price target by UBS reflects a positive outlook on Universal Health Servs, suggesting an expectation of stock price appreciation. Given the stock is trading below the new target, there's a clear short-term upside potential. The Neutral rating indicates that while UBS sees potential for growth, it might also have some reservations, possibly due to market conditions or company-specific factors.